Coeurative, Inc.
- Biotech or pharma, therapeutic R&D
The goal of Coeurative, Inc. is to create curative strategies for diseases associated with cellular hypoxia, like refractory angina secondary to coronary artery disease.
June 16-19, 2025
Boston Convention & Exhibition Center
The goal of Coeurative, Inc. is to create curative strategies for diseases associated with cellular hypoxia, like refractory angina secondary to coronary artery disease.